Quantcast

RZN Nutraceuticals Receives United States Patent & Trademark Office Notice of Allowance for Proprietary HerbaZorb(TM) Absorption and Delivery System Technology Used in Popular Arthri-Zen Relief(R) and Migra-Zen Relief PLUS(R) Products

September 11, 2009

MIAMI, Sept. 11 /PRNewswire/ — RZN Nutraceuticals, Inc.,(www.rznnutra.com) a leading developer of proven effective herbal products which have been clinically tested on sufferers of severe arthritis and migraines has announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for the firm’s absorption and delivery system process methodology patent application, a technology RZN has named HerbaZorb(TM). Two of the firm’s most popular product offerings, Arthri-Zen Relief(R) and Migra-Zen Relief(R) PLUS capsules already use the technology in their manufacture. The use of this preparation method ensures the rapid and effective absorption of active ingredients.

“We’re very pleased that the U.S. Patent and Trademark Office has recognized HerbaZorb as a patentable delivery system that allows herbal supplements and functional foods to be absorbed with full potency intact,” said Mark Lubin, founder of RZN Nutraceuticals, Inc., and a 25-year veteran biomedical engineer and research scientist in the fields of orthopedics, joint diseases, implantable cardiac devices, materials science and medical chemistry.

Among the proprietary characteristics of HerbaZorb noted in the patent application are that it protects beneficial phytochemicals of herbs and herbal extracts from being digested prior to entering the bloodstream, providing a significant advantage to both producers of herbal products and those who consume them. “The basis for our patent is that our delivery system represents a breakthrough in the field of bioavailability, the process by which active ingredients are delivered to the bloodstream intact, ensuring their maximum usefulness in the body.” Mr. Lubin commented.

According to company President Robert Hunt, “It is very satisfying to gain this important recognition for HerbaZorb, especially as we continue making the process available to other manufacturers who want us to prepare their herbal ingredients using this new technology.”

Clinical researchers have long studied the role absorption plays in the bioavailability of active ingredients ingested into the body. According to the Physician’s Desk Reference, only 10 to 20 percent of vitamins and minerals taken orally in tablet form are actually absorbed into the bloodstream.

“My goal has always been to develop the most effective and natural pain relief formulations possible, which resulted in the Arthri-Zen Relief(R) and Migra-Zen Relief(R) PLUS family of products,” Mr. Lubin stated. “With the advances in absorption offered by HerbaZorb, we can ensure that everyone in the industry using herbal blends can benefit from maximum bioavailability so the active ingredients in them are utilized most fully by the human body.”

RZN Nutraceuticals’ products are marketed direct to natural accounts, through private label, catalogue sales, practitioner offices, health clubs and on company’s website, www.rznnutra.com. Future distribution plans include national drug store chains and natural supplement outlets.

For more information on Migra-Zen Relief Plus(R) or the three Arthri-Zen Relief(R) formulations, visit www.rznnutra.com, or contact RZN President Robert Hunt 904-213-8232.

For media inquiries, contact Jennifer Bryan of Christie Communications (www.christiecomm.com) at 805-969-3744.

SOURCE RZN Nutraceuticals, Inc.


Source: newswire



comments powered by Disqus